David R. McGivern - Concepedia

Author

David R. McGivern

University of North Carolina at Chapel Hill ORCID

Also Known As

D McGivern, D R McGivern, D. MCGIVERN, D. McGivern, D. Mcgivern, D. R. McGivern, D.R. Mcgivern, Dansako, Hiromichi, David Mcgivern, David R McGivern

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill The University of Texas Medical Branch at Galveston North Carolina State University National Institute of Allergy and Infectious Diseases National Institute of Infectious Diseases

About

David R. McGivern is an author at University of North Carolina at Chapel Hill specializing in medicine, virology, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.3K
2	Natural Sciences	3	3	346
3	Biochemistry	3	3	278
4	Engineering	2	2	52
5	Health Sciences	1	1	10

David R. McGivern

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Competing and noncompeting activities of miR-122 and the 5′ exonuclease Xrn1 in regulation of hepatitis C virus replication You Li, Takahiro Masaki, Daisuke Yamane, Proceedings of the National Academy of Sciences	2012	221
Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation Daisuke Yamane, David R. McGivern, Eliane Wauthier, Nature Medicine Viral ReplicationBiochemistryViral HepatitisNatural SciencesLipid Peroxidation	2014	151
Hepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein Tsubasa Munakata, Yuqiong Liang, Seungtaek Kim, PLoS Pathogens Viral ReplicationHepatitis C VirusImmunologyRetinoblastoma ProteinPathology	2007	141
miR-122 Stimulates Hepatitis C Virus RNA Synthesis by Altering the Balance of Viral RNAs Engaged in Replication versus Translation Takahiro Masaki, Kyle C. Arend, You Li, Cell Host & Microbe Viral HepatitisViral Rnas EngagedImmunologyReplication Versus TranslationHepatitis	2015	136
Protease Inhibitor–Resistant Hepatitis C Virus Mutants With Reduced Fitness From Impaired Production of Infectious Virus Tetsuro Shimakami, Christoph Welsch, Daisuke Yamane, Gastroenterology Viral ReplicationViral HepatitisImmunologyAntiviral Drug DevelopmentHepatitis	2010	132
Is Hepatitis C Virus Carcinogenic? Stanley M. Lemon, David R. McGivern Gastroenterology HepatologyHepatitis CViral HepatitisHistopathologyHepatitis	2012	118
Kinetic Analyses Reveal Potent and Early Blockade of Hepatitis C Virus Assembly by NS5A Inhibitors David R. McGivern, Takahiro Masaki, Sara E. Williford, Gastroenterology BiochemistryViral HepatitisMedicineAntiviral Drug DevelopmentAntiviral Therapy	2014	107
MAVS-dependent host species range and pathogenicity of human hepatitis A virus Asuka Hirai-Yuki, Lucinda Hensley, David R. McGivern, Science Hepatotropic VirusesImmunologyPathologyInnate ImmunityMavs-dependent Host Species	2016	101
NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR Hui Feng, Erik M. Lenarcic, Daisuke Yamane, Nature Immunology Viral ReplicationViral ImmunityImmunologyAntiviral Drug DevelopmentAntiviral Response	2017	100
Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein Allan G. N. Angus, D.G. DALRYMPLE, Steeve Boulant, Journal of General Virology	2009	99

Page 1